Patient Recruitment

Selected news for the healthcare topic - Patient Recruitment, collected since 10/2017. There are 2.1K items in the archive. This healthcare topic shares news with COVID-19, Clinical Research, Clinical Trial Recruitment, Virtual Clinic, Clinerion and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/1/2022 Xtalks Announces its Life Science Webinar Calendar for June 2022 PRWeb ... OrganizationsJune 9- Using the Pain Catastrophizing Scale in Clinical Research and PracticeJune 14- Are You Ready for EU CTR? The Challenges, Lessons Learned and Innovations Surrounding the New RegulationJune 15- Maximizing Patient Recruitment Spend: Lessons on Reducing Site Burden and Increasing Diversity Through Optimized Pre-screeningJune 15- Commonly Overlooked Issues in CRO Selection — and How to Address ThemJune 16- Automating an End-to-End ...
5/31/2022 Insights on the Clinical Trials Matching Software Global Market to 2030 - Featuring IBM Clinical Development, Antidote Technologies and Advarra Among Others PR Newswire ... and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches. In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed ...
5/27/2022 The Worldwide Clinical Trial Patient Recruitment Services Industry is Expected to Reach $1.5 Billion by 2030 Yahoo News DUBLIN , May 27, 2022 /PRNewswire/ -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report by Service Type, by Phase, by Therapeutic Areas (Respiratory System, Oncology, Others), by Age Group, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.Research and Markets Logo The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR ...
5/27/2022 Outlook on the Clinical Trial Patient Recruitment Services Globe Newswire Dublin, The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report by Service Type, by Phase, by Therapeutic Areas (Respiratory System, Oncology, Others), by Age Group, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.0% during the forecast period. The growing ...
5/26/2022 Maximizing Patient Recruitment Spend: Lessons on Reducing Site Burden and Increasing Diversity Through Optimized Pre-screening, Upcoming Webinar Hosted by Xtalks PRWeb ... inclusive and culturally competent way. This ultimately improves diverse participation and reduces patient burden and anxiety. This solution delivers highly qualified participant referrals for sites — improving the return on investment (ROI) on digital patient recruitment efforts.Generating leads and finding potential participants for a study is only half of the battle. Those leads must advance through the pre-screening and screening stages before enrolling in a study, and that ...
5/26/2022 Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis heraldkeeper.com Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographies and therapeutic indications. A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient ...
5/17/2022 NextGen, Circuit Clinical offer providers support to run clinical trials FierceHealthcare ... According to Deloitte, hybrid trials between academic medical centers and community care providers made up to 50% of all trials in 2020 and some of 2021. Decentralized trials have also been found to reduce patient recruitment time, increase retention and patient interest and increase participation from communities of color.This trend is what duo NextGen and Circuit Clinical aim to tap into, now offering training and infrastructure support to providers ...
5/16/2022 Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies PR Newswire ... to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic MalignanciesPhase 1 dose escalation study will evaluate the safety and tolerability of combination therapy and determine the recommended dose for Phase 2 expansion Patient recruitment will commence in the coming weeks Supporting pre-clinical bexmarilimab hematology data was presented at recent European Hematology Association 2022 Congress Company Announcement, May 16, 2022 at 09:00 AM (EEST) / 07:00 AM (BST) / 2:00 ...
5/16/2022 Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies Yahoo News ... safety data, there is potential for Phase II expansion and to include a first line triplet therapy of bexmarilimab , azacitidine and venetoclax in newly diagnosed AML patients who are not able to tolerate chemotherapy. Patient recruitment is expected to begin in the coming weeks."We know from pre-clinical research, some of which was presented recently at EHA, that certain blood cancer cells, especially with myeloid background, carry significant amounts ...
5/16/2022 Thermo Fisher Scientific's Clinical Research Business Honored in CRO Leadership Awards Yahoo News ... product lifecycle management to ensure data integrity and patient safety. Utilizing patient-centered strategies and data analytics, PPD clinical research services cover multiple therapeutic areas, all phases of clinical development, peri- and post-approval, patient recruitment , investigator sites, comprehensive laboratory services, innovative and decentralized trial designs, and a purpose-built delivery model for biotech customers.In the 2022 CRO Leadership Awards, which recognize high-performing companies for exceptional customer service ...
5/13/2022 Nordic Nanovector ASA: Results for the First Quarter 2022 PR Newswire ... said : "The impacts from COVID-19 continued to linger during Q1 and meant the pick-up in recruitment into PARADIGME that we expected has not yet materialised. Nonetheless, we remain highly committed to completing patient recruitment for this important trial and expect to meet our timeline for readout of preliminary data in H2'2022. At the same time, our preparations for filing and commercialisation of Betalutin® are moving forward ...
5/12/2022 Considerations for Patient Diversity in Cardiovascular Clinical Trials, Upcoming Webinar Hosted by Xtalks PRWeb ... retention of diverse patient populations to ensure appropriate representation in clinical research.Join Hansie M. Mathelier, MD, FACC, Clinical Assistant Professor of Medicine, Penn Medicine; and experts from Medpace , Sara Sampaio, MD, CCRP, Manager, Patient Recruitment ; and Satya Shreenivas, MD, Medical Director, for the live webinar on Thursday, June 2, 2022, at 10am EDT (3pm BST/UK).For more information, or to register for this event, visit Considerations for Patient ...
5/12/2022 Immunome Reports First Quarter 2022 Financial Results | Business Wire Business Wire ... 31, 2022 and provided a corporate update.“We received FDA clearance to proceed with our Phase 1b clinical trial for our three-antibody cocktail, IMM-BCP-01, for the treatment of COVID-19 and patient recruitment efforts are underway. Based on the preclinical data, we believe this therapy can address the ongoing need for a substantial and effective COVID-19 antibody treatment, especially in light of the continued emergence of ...
5/12/2022 The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030 heraldkeeper.com ... eminent stakeholders in the industry- Several growth opportunities, driven by increasing volume of clinical trials, exist; some of these focus specially on the development of therapies for rare and complex indications- We expect the patient recruitment market for the services providers to increase steadily and grow by over 5% in the coming yearsFor more information, please visit https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245 ...
5/11/2022 Vial Launches VialConnect: a Modernized CTMS with Patient Recruitment Assistance Yahoo News ... VialConnect, an intuitive clinical trials management platform built for coordinators and investigators. VialConnect is offered at no cost and makes it simple for research sites to access Vial's modernized CTMS and additional services for patient recruitment.Vial Dermatology CRO logo (PRNewsfoto/Vial) Signing up for VialConnect gives sites access to two services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility ...
5/11/2022 Vial Launches VialConnect: a Modernized CTMS with Patient Recruitment Assistance Yahoo News ... VialConnect, an intuitive clinical trials management platform built for coordinators and investigators. VialConnect is offered at no cost and makes it simple for research sites to access Vial's modernized CTMS and additional services for patient recruitment.Vial Dermatology CRO logo (PRNewsfoto/Vial) Signing up for VialConnect gives sites access to two services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility ...
5/11/2022 Vial Launches VialConnect: a Modernized CTMS with Patient Recruitment Assistance PR Newswire ... VialConnect, an intuitive clinical trials management platform built for coordinators and investigators. VialConnect is offered at no cost and makes it simple for research sites to access Vial's modernized CTMS and additional services for patient recruitment.Signing up for VialConnect gives sites access to two services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility. And second, A HIPAA-compliant EMR ...
5/11/2022 Vial Introduces VialConnect: a Modernized CTMS with Patient Recruitment Assistance enterprisetalk.com ... an intuitive clinical trials management platform built for coordinators and investigators. VialConnect is offered at no cost and makes it simple for research sites to access Vial’s modernized CTMS and additional services for patient recruitment.Signing up for VialConnect gives sites access to two services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility. And second, A HIPAA-compliant EMR ...
5/11/2022 Vial Launches VialConnect: a Modernized CTMS with Patient Recruitment Assistance advfn.com ... VialConnect, an intuitive clinical trials management platform built for coordinators and investigators. VialConnect is offered at no cost and makes it simple for research sites to access Vial's modernized CTMS and additional services for patient recruitment.Signing up for VialConnect gives sites access to two services for free: First, a customizable CTMS (clinical trials management system) that powers core workflows and provides operational visibility. And second, A HIPAA-compliant EMR ...
5/9/2022 Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH cardiacvascularnews.com Rhythm]Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESHPARIS, May 09, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat hypertension and heart failure, announces today that it has recruited all planned patients in its phase III pivotal study FRESH, which ...